Microbiology
Specimens
3 simulated pharyngeal samples
Examinations
Nucleic acid detection
Important Notes
Molecular detection of Group A Streptococcus in pharyngeal samples. Four rounds per year.
Microbiology
Specimens
3 simulated urine specimens
Examinations
S. pneumoniae antigen detection
Important Notes
For clinical laboratories and POCT sites. Four rounds per year.
Microbiology
Specimens
3 simulated pharyngeal samples
Examinations
Antigen detection
Important Notes
For clinical laboratories and POCT sites. Four rounds per year.
Microbiology
Specimens
2 lyophilised samples. Samples include pathogens and/or normal flora
Examinations
Culture
Important Notes
See also product 5599 for direct nucleic acid detection. Four rounds per year.
Microbiology
Specimens
2 swab samples. Samples also include normal flora
Examinations
Direct nucleic acid detection
Important Notes
The samples contain hDNA. See also product 5594 for S. agalactiae (GBS) culture. Four rounds per year.
Microbiology
Specimens
1 lyophilised mixture of microbes; including pathogens and/or normal flora
Examinations
The scheme is intended for laboratories performing screening of VRE (vancomycin-resistant enterococci) by culture and/or direct nucleic acid detection method
Important Notes
VRE screening by culture and/or molecular methods for infection control purposes. Four rounds per year.
Microbiology
Specimens
1 lyophilised mixture of microbes; including pathogens and/or normal flora
Examinations
The scheme is intended for laboratories performing screening of multidrug resistant gramnegative rods (e.g. CPE, ESBL, MDR Acinetobacter and P. aeruginosa) by culture and/or direct nucleic acid detection method
Important Notes
Screening for multidrug resistant gram-negative bacteria including CPE, ESBL producers, and MDR Acinetobacter. Four rounds per year.
Microbiology
Specimens
1 lyophilised mixture of microbes; including pathogens and/or normal flora
Examinations
The scheme is intended for laboratories performing screening of MRSA (methicillin resistant Staphylococcus aureus) by culture and/or direct nucleic acid detection method
Important Notes
MRSA screening by culture and/or molecular methods for infection control purposes. Four rounds per year.
Clinical Chemistry
Specimens
2-3 slides prepared from patient samples
Examinations
Monosodium urate monohydrate and calcium pyrophosphate dihydrate crystals
Important Notes
Microscopic evaluation of synovial fluid crystals for arthritis diagnosis. Two rounds per year.
Microbiology
Specimens
2 liquid human serum samples, 0.6 mL. Authentic, commutable, single donor samples.
Examinations
Cardiolipin, Treponema pallidum antibodies, post-analytical clinical interpretation.
Important Notes
Clinical Chemistry
Specimens
2 liquid or lyophilised human serum samples, 5 mL.
Examinations
Amikasin, amitriptyline, carbamazepine, carbamazepine free, cyclosporine, digoxin, disopyramide, ethosuximide, flecainide, gentamycin, lidocaine, lithium, methotrexate, NAPA, netilmycin, nortriptyline, paracetamol (acetaminophen), phenobarbital, phenytoin, phenytoin free, primidone, procainamide, quinidine, salicylate, theophylline, tobramycin, tricyclics, valproic acid, valproic acid free, vancomycin.
Important Notes
Microbiology
Specimens
3 lyophilised mixtures of bacteria
Examinations
Culture and identification of group A, C and G streptococci
Important Notes
Culture and identification of beta-hemolytic streptococci from throat specimens. Four rounds per year.